共同受体神经林-1的小分子抑制剂
Yu-Heng Liu1, Kang-Hui Liang2, Wen Zhang2
1College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China; Zhejiang Key Laboratory of Green Manufacturing Technology for Chemical Drugs, Deqing 313200, PR China.
Drug discovery today
|November 3, 2025
概括
神经皮林-1 (NRP-1) 是癌症治疗的关键标,因为它在瘤生长和扩散中的作用. 本综述探讨了NRP-1的小分子抑制剂,提供了对它们的发展和未来癌症治疗机制的见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 神经蛋白-1 (NRP-1) 是细胞表面受体,参与神经发育,血管生成和免疫调节.
- NRP-1在病理性血管生成,瘤免疫逃逸和癌症进展中发挥着关键作用,使其成为一个重要的治疗点.
- 针对NRP-1的小分子抑制剂代表了癌症治疗中的一个有希望的新策略.
研究的目的:
- 审查神经皮林-1 (NRP-1) 小分子抑制剂的研究进展.
- 将现有的小分子抑制剂分为三种不同的类型.
- 提供关于这些抑制剂的开发策略,作用机制和当前研究状况的见解.
主要方法:
- 文献综述和对NRP-1小分子抑制剂研究的分析.
- 基于其化学结构或机制的抑制剂的分类.
- 综合有关发展理念,行动机制和研究状况的信息.
主要成果:
- NRP-1的小分子抑制剂分为三个主要类型.
- 详细讨论每个抑制剂类的开发方法和作用机制.
- 概述当前的研究环境和该领域的进展.
结论:
- NRP-1的小分子抑制剂对癌症治疗具有显著的潜力.
- 了解这些抑制剂的发展和机制对于未来的药物设计至关重要.
- 本综述为继续开发新型NRP-1向治疗提供了指导.
相关概念视频
01:32Pinching-off of Coated Vesicles
4.0K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
4.0K
01:42Phosphoinositides and PIPs
10.0K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.0K
01:15Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
556
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
556
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K